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ABSTRACT
Oxidative stress and mitochondrial failure promote altered protein degradation, reduced neurotransmission,
synapse loss and tau/hyperphosphorylation, which are early stages in the development of Alzheimer’s disease
(AD). A growing volume of data confirms that Ginkgo biloba extract (GBE) reduces oxidative stress and
improves mitochondrial respiration and thus may be useful in preventing or slowing down the progression
of AD. Treatment of Caenorhabditis elegans with GBE- extract reduces oxidative stress and extends median
lifespan compared with controls. Levels of reactive oxygen species, including the superoxide anion radical,
were reduced in brains from GBE-treated mice compared with controls. In older mice, GBE resulted in
a protective effect by increasing production of adenosine triphosphate in neurons. A respiratory experiment
indicated that GBE was able to rescue Aβ-induced defects in energy metabolism, with results suggesting long-
term regulatory effects on mitochondria. GBE also had a selective effect on the activities of mitochondrial
enzymes that assemble the electron transport system. The flavonoids, bilobalide and some of the ginkgolides (B
and J) had a high protective capacity, indicating that a combination of several compounds within standardized
Gingko biloba extracts contribute disproportionately for these protective effects.
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Introduction
Much of the current research into treatments for
Alzheimer’s disease (AD) focuses on dysfunction
of the amyloid cascade, which is traditionally
considered to be a linear sequence of events
(Figure 1). Certain events are active earlier in
the disease course: for example, oxidative stress
and mitochondrial failure promote altered protein
degradation, reduced neurotransmission, acceler-
ate synapse loss and tau-hyperphosphorylation.
Triggers such as genetics, age and environment
may affect processing of amyloid precursor protein
(APP) and hence generation of beta amyloid (Aβ),
which aggregates into amyloid oligomers and fibrils
and finally their deposition as plaques. Each event in
the amyloid cascade is an important trigger for the
changes that ultimately result in AD. Some agents
may be able to interfere with this cascade, providing
a degree of neuroprotection from the development
of this condition.
Correspondence should be addressed to: Anne Eckert, Neurobiology Laboratory
for Brain Aging and Mental Health, Assoc. Res. Group Dept. Biomedicine
Univ. of Basel, Psychiatric University Clinics Basel, Wilhelm Klein-Strasse 27,
CH-4025 Basel, Switzerland. Phone: +41 61 325 54 87, Fax: +41 61 325 55
77. Email: anne.eckert@upkbs.ch.
Oxidative stress and mitochondrial failure
Wu and colleagues used the model organism Caen-
orhabditis elegans to evaluate the pharmacological
effects of standardized Gingko biloba leaf special
extract EGb 761 R© on aging and to test the
hypothesis that this extract augments the natural
antioxidant system of C. elegans (Wu et al., 2002).
The results showed that treatment of wild-type
worms with EGb 761 reduces oxidative stress
and also extends median lifespan compared with
controls. EGb 761 is a dry extract from Ginkgo
biloba leaves (35–67:1), extraction solvent acetone
60% (w/w). The extract is adjusted to 22.0–27.0%
ginkgo flavonoids and 5.0–7.0% terpene lactones,
consisting of 2.8–3.4% ginkgolides A, B, and C and
2.6–3.2% bilobalide and contains less than 5 ppm
ginkgolic acids.
Mitochondria are producers of reactive oxygen
species (ROS), and dysfunction of the mitochondria
has a central role in aging and is an early event
in neurodegenerative diseases (Abdel-Kader et al.,
2007). Aged mice (18 months old) were treated
with EGb 761 for 14 days and the cortical brain
cells were then investigated post-mortem for the
presence of ROS using fluorescent dyes. Levels of
ROS and particularly the superoxide anion radical
O2− (an aggressive form of ROS formed as an
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Figure 1. Amyloid-β cascade hypothesis and potential intervention strategies.
unwanted by-product of mitochondrial respiration)
were reduced in brain cells from EGb 761-
treated mice compared with controls (placebo-
treated mice). EGb 761 thus provides antioxidant
effects.
A high mitochondrial membrane potential is
vital for the production of adenosine triphosphate
(ATP), which has an important role in intracellular
energy transfer. In a study by Eckert et al. (2005)
in aged mice (22 months old), brain cells were
isolated and subjected to oxidative stress through
the application of hydrogen peroxide. Control mice
exhibited a consequent reduction in membrane
potential, which was followed by a reduction in
production of ATP. In comparison, brain cells
from mice treated with Ginkgo biloba extract EGb
761 were protected from the effects of hydrogen
peroxide, which had a reduced effect on ATP
production. Shi et al. (2010) also investigated the
impact of EGb 761 on ATP production using
SAMP8 mice (a senescence-accelerated strain of
mouse). The hippocampi of two age groups of
mice (3 weeks and 40 weeks) were isolated and the
ATP content in the mitochondria was determined.
In young mice, EGb 761 had no effect on basal
production of ATP; however, treatment of older
mice with EGb 761 resulted in a protective effect,
with levels of ATP increasing.
A respiratory experiment in a closed chamber
investigated whether standardized Ginkgo biloba
extract was able to rescue Aβ-induced defects in
energy metabolism using whole cells (Rhein et al.,
2010). In this experiment, the respiratory capacity
of human neuroblastoma cells overexpressing
human wild-type amyloid precursor protein (APP)
and control cells (stably transfected with the
empty vector) was examined under physiological
conditions before and after treatment with
standardized Ginkgo biloba extract for 24 hours.
The oxygen concentration in the chamber decreases
once mitochondria begin to consume oxygen and
oxygen consumption (also called mitochondrial
respiration) can be measured. When compared
to control cells, APP transfected cells which
chronically overproduce Aβ showed a strong
reduction in respiratory capacity and coupling of
the mitochondrial electron transport chain. For
cells treated with Gingko biloba extract, however,
a general antioxidant effect led to an increase
in energy homeostasis and a reduction in ROS
levels in both control and APP cells. Importantly,
respiration remained improved in the Ginkgo biloba
extract-treated cells even after removal of the
extract, which suggests that the extract has long-
term regulatory effects on mitochondria. The
activities of mitochondrial enzymes that assemble
the electron transport system (ETS) were also
examined, with interesting results. Complex I
activity was significantly increased after APP cells
but not control cells were treated with Ginkgo biloba
extract (Figure 2A), whereas Complex II activity
was unaffected by Ginkgo biloba extract in both cell
lines. Complex III activity was markedly increased
in APP cells but normalized to the level of control
cells after treatment with Ginkgo biloba extract
(Figure 2B). Complex IV activity was decreased
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Figure 2. Modulation of mitochondrial enzyme activities by Gingko biloba extract in control and amyloid precursor protein (APP) cells.
Reproduced with permission from Rhein et al., 2010.
Table 1. Protective capacity of individual com-
pounds of EGb 761 in brain cells (n = 6–12)
COMPOUND M EAN (S E M) P R O T E C T I ON (%)
(0.5 mg/ml) (percentage recovery after insult)
....................................................................................................................................................
Ginkgolide A 8.0±1.9∗∗
Ginkgolide B 33.0±11.2∗
Ginkgolide C 8.5±1.6∗∗
Ginkgolide J 37.0±12.2∗
Bilobalide 36.3±7.7∗∗
Flavonoids 56.4±12.7∗∗∗
SEM = standard error mean.
∗P < 0.05 versus no insult; ∗∗P < 0.01 versus no insult;
∗∗∗P < 0.001 versus no insult.
in APP cells but significantly increased in control
and APP cells after treatment with Ginkgo biloba
extract (Figure 2C). The reason for the specific
effect of the drug on activity of the different
mitochondrial enzymes is unclear, but it may relate
to normalization of the Aβ-induced disturbance in
the activity of complexes III and IV.
When the effects of the component compounds
of Ginkgo biloba extract on membrane protection
were compared, the flavonoids, bilobalide and
some of the ginkgolides (B and J) had a high
protective capacity (Table 1), which indicates that
a combination of several compounds within the
extract may contribute disproportionately for its
protective effects. This is interesting, because the
extract has a large effect on the mitochondrial
DNA compared to levels in controls and APP-
transected cells. This may indicate that activity of
certain complexes is increased and is important
for protective effects in terms of mitochondrial
dysfunction.
Summary
A meaningful selection of data confirms that
Ginkgo biloba extract has beneficial effects in
terms of reducing oxidative stress and improving
mitochondrial respiration, which may be useful in
preventing the early stages of AD.
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